Koo Ja Seung, Kim Haeryoung
Department of Pathology, Yonsei University Health System, 250 Seongsan-ro, Seodaemun-gu, Seoul, South Korea.
Tumour Biol. 2011 Oct;32(5):893-904. doi: 10.1007/s13277-011-0190-5. Epub 2011 May 20.
Carcinoma of unknown primary (CUP) is a heterogeneous entity with different clinical and histological features. The aim of this study was to investigate the clinicopathological features and expression of proteins associated with carcinogenesis and tumor environment in different histological subtypes of CUP. Sixty-nine cases of CUP were subjected to immunohistochemistry for EGFR, phospho-EGFR, HER-2, phospho-HER-2, p53, ERCC1, RRM1, REDD1, HIF1α, COX-2, GLUT-1, 14-3-3σ, Phospho-mTOR, Phospho-S6, AMPKα1, Phospho-Akt, PDGF-β receptor, and caveolin-1, and fluorescence in situ hybridization for HER-2 gene amplification. Fourteen (20.3%) cases were poorly differentiated carcinoma, 24 (34.8%) were adenocarcinoma (AD), 17 (24.6%) were squamous cell carcinoma (SC), and 14 (20.3%) were undifferentiated carcinoma (UD). AD were mostly carcinomatosis type, while SC and UD were mostly nodal type (p < 0.001). SC showed more frequent EGFR overexpression (p < 0.001) and Glut-1 (p = 0.001). AD (p = 0.001) and carcinomatosis (p < 0.001) types showed shorter overall survival. SCs expressing Glut-1, HIF1α, and COX2 showed a poor prognosis (p = 0.048, 0.029, and 0.042, respectively). CUP shows various clinicopathological features according to the histological subtypes. SC is mainly associated with nodal metastasis in the head and neck, and frequent EGFR overexpression and Glut-1 expression. Glut-1, HIF1α, and COX2 expression in SC is associated with a poor prognosis.
原发灶不明癌(CUP)是一种具有不同临床和组织学特征的异质性实体。本研究的目的是调查CUP不同组织学亚型中与致癌作用和肿瘤环境相关的临床病理特征及蛋白质表达。对69例CUP病例进行了表皮生长因子受体(EGFR)、磷酸化表皮生长因子受体(phospho-EGFR)、人表皮生长因子受体2(HER-2)、磷酸化人表皮生长因子受体2(phospho-HER-2)、p53、切除修复交叉互补蛋白1(ERCC1)、核糖核苷酸还原酶M1(RRM1)、DNA损伤应答调控蛋白1(REDD1)、低氧诱导因子1α(HIF1α)、环氧化酶-2(COX-2)、葡萄糖转运蛋白1(GLUT-1)、14-3-3σ、磷酸化哺乳动物雷帕霉素靶蛋白(Phospho-mTOR)、磷酸化核糖体蛋白S6(Phospho-S6)、腺苷酸活化蛋白激酶α1(AMPKα1)、磷酸化蛋白激酶B(Phospho-Akt)、血小板衍生生长因子-β受体(PDGF-β receptor)和小窝蛋白-1(caveolin-1)的免疫组织化学检测,以及HER-2基因扩增的荧光原位杂交检测。14例(20.3%)为低分化癌,24例(34.8%)为腺癌(AD),17例(24.6%)为鳞状细胞癌(SC),14例(20.3%)为未分化癌(UD)。腺癌多为癌性淋巴管播散型,而鳞状细胞癌和未分化癌多为淋巴结型(p<0.001)。鳞状细胞癌显示更频繁的EGFR过表达(p<0.001)和葡萄糖转运蛋白1(p=0.001)过表达。腺癌(p=0.001)和癌性淋巴管播散型(p<0.001)的总生存期较短。表达葡萄糖转运蛋白1、低氧诱导因子1α和环氧化酶-2的鳞状细胞癌预后较差(分别为p=0.048、0.029和0.042)。根据组织学亚型,原发灶不明癌表现出各种临床病理特征。鳞状细胞癌主要与头颈部淋巴结转移、频繁的EGFR过表达和葡萄糖转运蛋白1表达相关。鳞状细胞癌中葡萄糖转运蛋白1、低氧诱导因子1α和环氧化酶-2的表达与预后不良相关。